CSL Expands Global Customer Engagement Transformation with Salesforce Agentforce Life Sciences
CSL deploys Salesforce Agentforce across commercial and medical operations—not a pilot, live transformation.
Why it matters
Enterprise life sciences company moves beyond pilot to scale AI agents in customer engagement and medical workflows. Shows how vertical-specific AI tooling (Salesforce's Life Sciences variant) is driving adoption in regulated industries.
The key facts
10 to knowCSL expanding Salesforce Agentforce deployment
Use case: commercial and medical operations customer engagement
Announced May 14, 2026
Part of broader digital transformation initiative
Life Sciences-specific AI agent configuration
Salesforce partnership expansion
Application span: commercial and medical operations
Life sciences/biotech vertical adoption
Published May 14, 2026
Expansion of existing partnership (not new deal)
Go to the source
Salesforce Newsroomsalesforce.com
Publisher excerpt: May 14, 2026 — CSL, a global leader in developing lifesaving protein biotherapies for people with rare and serious diseases, is continuing to evolve its digital and customer engagement transformation across its commercial and medical operations. As part of this effort, today we announced that CSL…